Literature DB >> 4922276

A controlled clinical trial of lactulose in hepatic encephalopathy.

F Simmons, H Goldstein, J D Boyle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4922276

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  14 in total

Review 1.  Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

Authors:  Bodil Als-Nielsen; Lise L Gluud; Christian Gluud
Journal:  BMJ       Date:  2004-03-30

Review 2.  Management of overt hepatic encephalopathy.

Authors:  Praveen Sharma; Barjesh C Sharma
Journal:  J Clin Exp Hepatol       Date:  2014-05-10

Review 3.  Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.

Authors:  G S Avery; E F Davies; R N Brogden
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 4.  Lactulose: A Simple Sugar in a Complex Encephalopathy.

Authors:  Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2018-04       Impact factor: 3.210

5.  Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy.

Authors:  R E Tarter; A M Hegedus; D H Van Thiel; R R Schade; J S Gavaler; T E Starzl
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

Review 6.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

7.  Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.

Authors:  F Orlandi; U Freddara; M T Candelaresi; A Morettini; G R Corazza; A Di Simone; G Dobrilla; G Cavallini
Journal:  Dig Dis Sci       Date:  1981-06       Impact factor: 3.199

Review 8.  Disaccharides in the treatment of hepatic encephalopathy.

Authors:  Praveen Sharma; Barjesh Chander Sharma
Journal:  Metab Brain Dis       Date:  2013-03-02       Impact factor: 3.584

9.  Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.

Authors:  C E Atterbury; W C Maddrey; H O Conn
Journal:  Am J Dig Dis       Date:  1978-05

10.  Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.

Authors:  Yong Han Paik; Kwan Sik Lee; Kwang Hyub Han; Kun Hoon Song; Myoung Hwan Kim; Byung Soo Moon; Sang Hoon Ahn; Se Joon Lee; Hyo Jin Park; Dong Ki Lee; Chae Yoon Chon; Sang In Lee; Young Myoung Moon
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.